Voriconazole Induced Ocular Surface Dysplasia - Report of Two Cases

Ocul Immunol Inflamm. 2022 Jan 2;30(1):210-214. doi: 10.1080/09273948.2020.1781903. Epub 2020 Aug 13.

Abstract

Purpose: To report ocular surface dysplasia induced by voriconazole treatment in two patients with recalcitrant fungal keratitis.

Methods: Observational study.

Results: Case 1 - A 49 year old female who was a known case of fungal keratitis and treated with prolonged topical voriconazole therapy, underwent penetrating keratoplasty and the histopathological examination of corneal specimen showed multiple keratin pearls with dyskeratotic cells suggestive of squamous cell carcinoma.Case 2 - A 78-year-old man who was diagnosed as fungal keratitis in his left eye and treated with topical voriconazole 1% and itraconazole 1% for 6 months underwent therapeutic penetrating keratoplasty. Histopathology of the host corneal tissue showed squamous cells with irregular thickening with dyskeratotic cells and squamous eddies suggestive of voriconazole induced dysplasia.

Conclusion: Prolonged topical voriconazole treatment in fungal keratitis can induce ocular surface dysplasia. Early diagnosis and treatment of the dysplastic changes can result in complete remission and prevent recurrence.

Keywords: Voriconazole; fungal keratitis; photosensitivity; squamous cell carcinoma.

Publication types

  • Case Reports
  • Observational Study

MeSH terms

  • Aged
  • Antifungal Agents / adverse effects
  • Cornea / pathology
  • Eye Infections, Fungal* / diagnosis
  • Eye Infections, Fungal* / drug therapy
  • Eye Infections, Fungal* / microbiology
  • Female
  • Humans
  • Keratitis* / chemically induced
  • Keratitis* / diagnosis
  • Keratitis* / drug therapy
  • Male
  • Middle Aged
  • Voriconazole / adverse effects

Substances

  • Antifungal Agents
  • Voriconazole